SV Health Investors’s Sutro Biopharma STRO Stock Holding History

SV Health Investors’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-182,454	Closed	-$27.1M	–	6
2021 Q4	$27.1M	Hold	182,454	–	–	17.55%	3
2021 Q3	$34.5M	Hold	182,454	–	–	16.87%	4
2021 Q2	$33.9M	Hold	182,454	–	–	14.78%	4
2021 Q1	$41.5M	Hold	182,454	–	–	15.56%	3
2020 Q4	$39.6M	Hold	182,454	–	–	19.08%	2
2020 Q3	$18.3M	Hold	182,454	–	–	9.29%	6
2020 Q2	$14.2M	Hold	182,454	–	–	9.82%	6
2020 Q1	$18.6M	Hold	182,454	–	–	15.61%	3
2019 Q4	$20.1M	Hold	182,454	–	–	12.16%	5
2019 Q3	$16.6M	Hold	182,454	–	–	11.65%	6
2019 Q2	$20.8M	Hold	182,454	–	–	13.94%	3
2019 Q1	$20.8M	Hold	182,454	–	–	12.19%	4
2018 Q4	$16.5M	Hold	182,454	–	–	10.13%	4
2018 Q3	$27.4M	Buy	+182,454	New	+$27.6M	8.01%	5

Other funds holding STRO

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Holocene Advisors

Holocene Advisors New York $41.3B AUM 42.97% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return